Risk Factors for and Management of Postpancreatectomy Hepatic Steatosis

Area of Science:

• Gastroenterology and Hepatology
• Surgical Oncology
• Medical Imaging

Background:

• Postpancreatectomy hepatic steatosis is a poorly understood complication following pancreatic surgery.
• Identifying risk factors and effective treatments is crucial for patient outcomes.

Purpose of the Study:

• To investigate the risk factors associated with the development of postpancreatectomy hepatic steatosis.
• To evaluate the efficacy of different digestive enzyme replacement therapy doses in managing this condition.

Main Methods:

• Retrospective review of 253 patients undergoing pancreaticoduodenectomy or total pancreatectomy between 2005 and 2010.
• Analysis of patient demographics, operative details, and post-operative imaging to identify risk factors.
• Comparison of outcomes for patients receiving maintenance- versus high-dose digestive enzyme replacement therapy.

Main Results:

• Hepatic steatosis developed in 29.6% of patients.
• Independent risk factors identified include female gender, BMI > 22.5 kg/m², operative duration > 540 min, and delayed gastric emptying.
• High-dose digestive enzyme therapy improved hepatic steatosis in 80% of eligible patients, compared to 17.1% on maintenance doses (p=0.006).

Conclusions:

• Female gender, obesity, prolonged operative time, and delayed gastric emptying are significant risk factors for postpancreatectomy hepatic steatosis.
• High-dose digestive enzyme replacement therapy appears to be an effective treatment for improving postpancreatectomy hepatic steatosis.